OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
May 20, 2022
Catalent has announced a $175 million project to expand its manufacturing facility for large scale oral dose forms at its Winchester, Ky, site.
April 02, 2022
Meeting patient needs and achieving high quality are common goals for all stakeholders.
March 17, 2022
Catalent has announced the completion of a $30 million project at its facility in Limoges, France focused on biopharmaceutical development and drug product manufacturing.
February 01, 2022
CDMOs offer expertise and capacity for spray drying.
September 24, 2021
Researchers in China report test results for a microneedle patch for COVID-19 vaccine delivery.
September 16, 2021
Considering interactions and understanding regulatory requirements are crucial when developing a drug or biologic product for use with a medical device.
July 16, 2021
ImmunityBio will proceed with a Phase I/II/III trial in South Africa of their dual-antigen T-cell vaccine as a boost in participants who were previously vaccinated against COVID-19.
July 12, 2021
UltraBurst has a high disintegration speed, which is for all market segments, from prescriptions to nutraceuticals.
May 03, 2021
Aprecia and Glatt investigate manufacturing technologies to widen the formulation design space for oral delivery.
April 21, 2021
The collaboration will evaluate Nanoform’s fast dissolution nanoparticles in Aprecia’s ZipDose 3DP technology platform for buccal and oral drug delivery.